{"id":"tegaderm-hydrogel","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin maceration (excessive moisture)"},{"rate":null,"effect":"Allergic contact dermatitis"},{"rate":null,"effect":"Wound infection"}]},"_chembl":{"chemblId":"CHEMBL1616046","moleculeType":"Small molecule","molecularWeight":"52.46"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The hydrogel formulation absorbs wound fluid while simultaneously releasing water to rehydrate dry, devitalized tissue, promoting autolytic debridement and facilitating the body's natural healing processes. This moist wound environment supports granulation tissue formation and epithelialization while protecting the wound from bacterial contamination and external trauma.","oneSentence":"Tegaderm Hydrogel is a moisture-donating wound dressing that maintains a moist healing environment by absorbing exudate and providing hydration to dry or necrotic tissue.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:11:20.100Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Partial and full-thickness wounds"},{"name":"Pressure ulcers"},{"name":"Diabetic foot ulcers"},{"name":"Venous leg ulcers"},{"name":"Surgical wounds"},{"name":"Burn wounds"},{"name":"Donor sites"}]},"trialDetails":[{"nctId":"NCT04887688","phase":"NA","title":"Exciflex for Chronic Wound Therapy","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-10-05","conditions":"Chronic Wound, Diabetes, Spinal Cord Injury","enrollment":16},{"nctId":"NCT01368146","phase":"PHASE1","title":"Human Repeat Insult Patch Test of Wound Dressings","status":"COMPLETED","sponsor":"Covalon Technologies Inc.","startDate":"2011-03","conditions":"Skin Sensitization","enrollment":216},{"nctId":"NCT02813213","phase":"PHASE4","title":"Effectiveness Comparison of Skin Micro-grafts vs Meshed Split Thickness Skin Grafts","status":"UNKNOWN","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2016-06","conditions":"Skin Ulcer, Burns","enrollment":30},{"nctId":"NCT01368120","phase":"PHASE1","title":"Antimicrobial Activity of IV Clear™ Dressing - Prevention of Antimicrobial Regrowth","status":"COMPLETED","sponsor":"Covalon Technologies Inc.","startDate":"2011-04","conditions":"Skin Flora Infection","enrollment":37},{"nctId":"NCT00971048","phase":"NA","title":"Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds","status":"COMPLETED","sponsor":"Healthpoint","startDate":"2009-09","conditions":"Diabetic Foot Ulcers, Pressure Ulcers","enrollment":88},{"nctId":"NCT01143727","phase":"PHASE4","title":"Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Healthpoint","startDate":"2010-07","conditions":"Diabetic Foot Ulcers","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":47,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Tegaderm Hydrogel","genericName":"Tegaderm Hydrogel","companyName":"Healthpoint","companyId":"healthpoint","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tegaderm Hydrogel is a moisture-donating wound dressing that maintains a moist healing environment by absorbing exudate and providing hydration to dry or necrotic tissue. Used for Partial and full-thickness wounds, Pressure ulcers, Diabetic foot ulcers.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}